Global Hospital Infection Therapeutics Market 2017 Share, Size, Forecast 2022

Published On: Nov 2017

Format: PDF

Publisher: QY Research

Pages: 102

Report ID: 131225

In this report, the global Hospital Infection Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hospital Infection Therapeutics in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Hospital Infection Therapeutics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Sanofi
Pfizer
Merck
Bayer
Johnson & Johnson
AstraZeneca
Actavis
Bristol-Myers Squibb Company
Cubist Pharmaceuticals
GlaxoSmithKline
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Hospital Infection Therapeutics for each application, including
Hospital-Acquired Pneumonia
Urinary Tract Infections
Gastrointestinal Disorders
Bloodstream Infections
Surgical Site Infections
Other Hospital Infections

Table of Contents

Global Hospital Infection Therapeutics Market Research Report 2017
1 Hospital Infection Therapeutics Market Overview
1.1 Product Overview and Scope of Hospital Infection Therapeutics
1.2 Hospital Infection Therapeutics Segment by Type (Product Category)
1.2.1 Global Hospital Infection Therapeutics Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Hospital Infection Therapeutics Production Market Share by Type (Product Category) in 2016
1.2.3 Antibacterial Drugs
1.2.4 Antiviral Drugs
1.2.5 Antifungal Drugs
1.3 Global Hospital Infection Therapeutics Segment by Application
1.3.1 Hospital Infection Therapeutics Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospital-Acquired Pneumonia
1.3.3 Urinary Tract Infections
1.3.4 Gastrointestinal Disorders
1.3.5 Bloodstream Infections
1.3.6 Surgical Site Infections
1.3.7 Other Hospital Infections
1.4 Global Hospital Infection Therapeutics Market by Region (2012-2022)
1.4.1 Global Hospital Infection Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Hospital Infection Therapeutics (2012-2022)
1.5.1 Global Hospital Infection Therapeutics Revenue Status and Outlook (2012-2022)
1.5.2 Global Hospital Infection Therapeutics Capacity, Production Status and Outlook (2012-2022)

2 Global Hospital Infection Therapeutics Market Competition by Manufacturers
2.1 Global Hospital Infection Therapeutics Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Hospital Infection Therapeutics Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Hospital Infection Therapeutics Production and Share by Manufacturers (2012-2017)
2.2 Global Hospital Infection Therapeutics Revenue and Share by Manufacturers (2012-2017)
2.3 Global Hospital Infection Therapeutics Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Hospital Infection Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Hospital Infection Therapeutics Market Competitive Situation and Trends
2.5.1 Hospital Infection Therapeutics Market Concentration Rate
2.5.2 Hospital Infection Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Hospital Infection Therapeutics Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Hospital Infection Therapeutics Capacity and Market Share by Region (2012-2017)
3.2 Global Hospital Infection Therapeutics Production and Market Share by Region (2012-2017)
3.3 Global Hospital Infection Therapeutics Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Hospital Infection Therapeutics Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Hospital Infection Therapeutics Consumption by Region (2012-2017)
4.2 North America Hospital Infection Therapeutics Production, Consumption, Export, Import (2012-2017)
4.3 Europe Hospital Infection Therapeutics Production, Consumption, Export, Import (2012-2017)
4.4 China Hospital Infection Therapeutics Production, Consumption, Export, Import (2012-2017)
4.5 Japan Hospital Infection Therapeutics Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Hospital Infection Therapeutics Production, Consumption, Export, Import (2012-2017)
4.7 India Hospital Infection Therapeutics Production, Consumption, Export, Import (2012-2017)

5 Global Hospital Infection Therapeutics Production, Revenue (Value), Price Trend by Type
5.1 Global Hospital Infection Therapeutics Production and Market Share by Type (2012-2017)
5.2 Global Hospital Infection Therapeutics Revenue and Market Share by Type (2012-2017)
5.3 Global Hospital Infection Therapeutics Price by Type (2012-2017)
5.4 Global Hospital Infection Therapeutics Production Growth by Type (2012-2017)

6 Global Hospital Infection Therapeutics Market Analysis by Application
6.1 Global Hospital Infection Therapeutics Consumption and Market Share by Application (2012-2017)
6.2 Global Hospital Infection Therapeutics Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Hospital Infection Therapeutics Manufacturers Profiles/Analysis
7.1 Sanofi
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Hospital Infection Therapeutics Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Sanofi Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Pfizer
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Hospital Infection Therapeutics Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Pfizer Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Merck
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Hospital Infection Therapeutics Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Merck Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Bayer
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Hospital Infection Therapeutics Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Bayer Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Johnson & Johnson
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Hospital Infection Therapeutics Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Johnson & Johnson Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 AstraZeneca
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Hospital Infection Therapeutics Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 AstraZeneca Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Actavis
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Hospital Infection Therapeutics Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Actavis Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Bristol-Myers Squibb Company
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Hospital Infection Therapeutics Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Bristol-Myers Squibb Company Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Cubist Pharmaceuticals
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Hospital Infection Therapeutics Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Cubist Pharmaceuticals Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 GlaxoSmithKline
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Hospital Infection Therapeutics Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 GlaxoSmithKline Hospital Infection Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview

8 Hospital Infection Therapeutics Manufacturing Cost Analysis
8.1 Hospital Infection Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Hospital Infection Therapeutics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Hospital Infection Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Hospital Infection Therapeutics Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Hospital Infection Therapeutics Market Forecast (2017-2022)
12.1 Global Hospital Infection Therapeutics Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Hospital Infection Therapeutics Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Hospital Infection Therapeutics Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Hospital Infection Therapeutics Price and Trend Forecast (2017-2022)
12.2 Global Hospital Infection Therapeutics Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Hospital Infection Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Hospital Infection Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Hospital Infection Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Hospital Infection Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Hospital Infection Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Hospital Infection Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Hospital Infection Therapeutics Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Hospital Infection Therapeutics Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer